Severe atherosclerotic cardiovascular disease (ASCVD) is often diagnosed too late, with significant arterial damage and a high risk of major adverse coronary events (MACE). Urgent identification and treatment of high-risk patients are critical to interrupt the atherosclerotic process and prevent life-threatening events, particularly acute coronary syndrome (ACS). Intensive lipid lowering, especially targeting low-density lipoprotein cholesterol (LDL-C), can stabilize coronary plaques. Get ahead of the curve and join our distinguished panel of experts who will guide you in identifying patients at high risk of an ACS event and implementing evidence-based intensive lipid-lowering strategies to reduce CV risk.
To attend this symposium, whether in person or virtually, you must first register directly with the ESC CONGRESS 2025.
Please visit the official congress website for full registration details and requirements.
MODERATOR / COURSE DIRECTOR
Deepak L. Bhatt, MD, MPH, MBA
Professor of Cardiovascular Medicine
Director, Mount Sinai Fuster Heart Hospital
Icahn School of Medicine at Mount Sinai
New York, New York, United States
FACULTY
J. Wouter Jukema, MD, PhD
Professor of Cardiology
Leiden University Medical Center
Leiden, the Netherlands
FACULTY
Pasquale Perrone-Filardi, MD, PhD
Professor of Cardiology
University of Naples Federico II
Naples, Italy
FACULTY
Lale Tokgözoğlu, MD
Professor of Cardiology
Hacettepe University
Ankara, Turkey
10:00 TZ
10:10 TZ
10:20 TZ
10:30 TZ
10:35 TZ
Av. del Partenón, 5, Barajas, Madrid, Spain, 28042
Room: Sofia